Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Geriatric Assessment and StratificationLarocca, AClinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e7-e7 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Impact of complete response on progression-free survival and overall survival in newly diagnosed myeloma patients treated with autologous stem cell transplantation or conventional chemotherapy: results of a pooled analysis of 5 phase III trialsMina, R ; Larocca, A ; Offidani, M ; Magarotto, V ; Caravita, T ; van der Holt, R ; Di Raimondo, F ; Bosi, A ; Vincelli, I.D ; Croockewit, S ; Gaidano, G ; Grandi, S ; Musolino, C ; Cerrato, C ; Lud k, P ; Ruggeri, M ; Rossi, G ; Rossini, F ; Petrucci, M.T ; Ria, R ; Zweegman, S ; Hajek, R ; Spencer, A ; Boccadoro, M ; Sonneveld, P ; Palumbo, AClinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e53-e54 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Weekly Carfilzomib in combination with cyclophosphamide and dexamethasone (wCCyd) in patients (pts) with newly diagnosed Multiple Myeloma (NDMM): a phase 1/2 study of the European Myeloma Network Trialist GroupBringhen, S ; Gay, F ; Rossi, D ; Larocca, A ; Gentilini, F ; Galieni, P ; Malfitano, A ; Omedé, P ; Offidani, M ; Liberati, A.M ; Gaidano, G ; Boccadoro, M ; Sonneveld, P ; Corradini, P ; Palumbo, AClinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e70-e70 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Early Mortality in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel AgentsLarocca, A ; Bringhen, S ; Petrucci, M.T ; Offidani, M ; Benevolo, G ; Galli, M ; Patriarca, F ; Ballanti, S ; Palladino, C ; Pescosta, N ; Grasso, M ; Evangelista, A ; Spada, S ; Pezzati, S ; Pulini, S ; Bernardini, A ; Rota-Scalabrini, D ; Morabito, F ; Tosi, P ; Oliva, S ; Baldini, M ; Marasca, R ; Finsinger, P ; Cellini, C ; Ria, R ; Aitoro, G ; Hajek, R ; Boccadoro, M ; Palumbo, AClinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e42-e43 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
P-392 Daratumumab-induced in vivo immune modulation in relapsed and/refractory multiple myeloma patients treated with daratumumab-len-dexGiannotta, Claudia ; Ziccheddu, Bachisio ; D'Agostino, Mattia ; Bertuglia, Giuseppe ; Saraci, Elona ; Oliva, Stefania ; Bolli, Niccolo' ; Landgren, Ola ; Bruno, Benedetto ; Boccadoro, Mario ; Maura, Francesco ; Massaia, Massimo ; Larocca, AlessandraClinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S256-S257 [Periódico revisado por pares]Texto completo disponível |
6 |
Material Type: Artigo
|
![]() |
OA-44 Pomalidomide, bortezomib, and dexamethasone vs bortezomib and dexamethasone in relapsed or refractory multiple myeloma (OPTIMISMM): final survival outcomes from a randomized, open-label, phase 3 trialBeksac, Meral ; Richardson, Paul ; Oriol, Albert ; Lindsay, Jindriska ; Schjesvold, Fredrik ; Galli, Monica ; Yağci, Münci ; Larocca, Alessandra ; Weisel, Katja ; Yu, Xin ; Donahue, Cynthia ; Acosta, Jorge ; Peluso, Teresa ; Dimopoulos, MeletiosClinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S27-S28 [Periódico revisado por pares]Texto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose AdjustmentOriol, Albert ; Dimopoulos, Meletios ; Schjesvold, Fredrik ; Beksac, Meral ; Facon, Thierry ; Dhanasiri, Sujith ; Guo, Shien ; Mu, Yutian ; Hong, Kevin ; Gentili, Christian ; Galli, Monica ; Yagci, Munci ; Larocca, Alessandra ; Richardson, Paul ; Weisel, KatjaClinical lymphoma, myeloma and leukemia, 2024-03, Vol.24 (3), p.165-176.e4 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
P-253: Impact of adjusting bortezomib dose in the pomalidomide, bortezomib, and dexamethasone (PVd) combination: a post hoc analysis of the OPTIMISMM studyLarocca, Alessandra ; Weisel, Katja ; Galli, Monica ; Oriol, Albert ; Facon, Thierry ; Dhanasiri, Sujith ; Hong, Kevin ; Gentili, Christian ; Mu, Yutian ; Guo, Shien ; Schjesvold, Fredrik ; Dimopoulos, Meletios A. ; Richardson, PaulClinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S175 [Periódico revisado por pares]Texto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose AdjustmentOriol, Albert ; Dimopoulos, Meletios ; Schjesvold, Fredrik Hellem ; Beksac, Meral ; Facon, Thierry ; Dhanasiri, Sujith ; Guo, Shien ; Mu, Yutian ; Hong, Kevin ; Gentili, Christian ; Galli, Monica ; Yagci, Munci ; Larocca, Alessandra ; Richardson, Paul ; Weisel, KatjaClinical lymphoma, myeloma and leukemia, 2023 [Periódico revisado por pares]CIG Media Group, LPTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
P-191: The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: a systematic reviewMian, Hira ; McCurdy, Arleigh ; Giri, Smith ; Grant, Shakira ; Rochwerg, Bram ; Winks, Erica ; Rosko, Ashley ; Engelhardt, Monika ; Pawlyn, Charlotte ; Cook, Gordon ; Jackson, Graham ; Brighen, Sara ; Facon, Thierry ; Larocca, Alessandra ; Zweegman, Sonja ; Wildes, TanyaClinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S140 [Periódico revisado por pares]Texto completo disponível |